Encouraging data for a neoantigen vaccine vs triple-negative breast cancer, revving up the immune system with favorable outcomes compared with historic controls (Phase 1 trial)
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-024-01388-3
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-024-01388-3
1 / 2
Comments